In addition to the suppressive function in solid tumors, IL-37 was also found associated with the progression of AML, which is a hematological malignancy that generally affects the elderly (>65 years old) and is the most common acute leukemia occurs in adults (133). Here, IL37 is linked to acute myeloid leukemia.